Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 140, Issue 1, 2008, Pages 95-102

  Li, Zhengyu ^a   Liu, Yi ^a   Zhao, Xia ^a   Pan, Xiaoling ^a   Yin, Rutie ^a   Huang, Canhua ^b   Chen, Lijuan ^b   Wei, Yuquan ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Honokiol; Ovarian tumor

Indexed keywords

CASPASE 3; HONOKIOL; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 49649114129     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.02.023     Document Type: Article

References (31)

1. Teng C.M., Chen C.C., Ko F.N., et al. Two antiplatelet agents from Magnolia officinalis. Thromb Res 50 6 (1988) 757-765
2. Kuribara H., Stavinoha W.B., and Maruyama Y. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 50 7 (1998) 819-826
3. Wang T., Chen F., Chen Z., et al. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 10 15 (2004) 2205-2208
4. L , release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 63 9 (2002) 1641-1651
5. 3 and retinoic acid. Int J Biochem Cell Biol 37 2 (2005) 427-441
6. Hibasami H., Achiwa Y., Katsuzaki H., et al. Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 2 6 (1998) 671-673
7. Hoskins W.J., Mcguire W.P., Brady M.F., et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 174 4 (1994) 974-979
8. Wu Y., Li Z.Y., Zhao X., Kan B., and Wei Y.Q. Inhibition of ovarian tumor growth by gene therapy with recombinant soluble vascular endothelial growth factor receptor 2. Hum Gene Ther 17 9 (2006) 941-948
9. Chakraborty S., Ghosh U., Bhattacharyya N.P., Bhattacharya R.K., and Roy M. Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res 596 1/2 (2006) 81-90
10. Singh S., and Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6 3 (2006) 259-270
11. Baek S.J., Kim J.S., Jackson E.R., Eling T.E., McEntee M.F., and Lee S.H. Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis 25 12 (2004) 24425-24432
12. Young M., and Plosker G.L. Paclitaxel: a pharmacoeconomic review of its use in the treatment of ovarian caner. Pharmacoeconomics 19 12 (2001) 1227-1259
13. Symmans F.W. Breast cancer response to paclitaxel in vivo. Drug Resist Update 4 5 (2001) 297-302
14. Bai X., Cerimele F., Ushio-Fukai M., et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278 37 (2003) 35501-35507
15. Chen F., Wang T., Wu Y.F., et al. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 10 23 (2004) 3459-3463
16. Wolf I., O'Kelly J., Wakimoto N., et al. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 30 6 (2007) 1529-1537
17. Beobyi L., Cheorl H.K., and Sung K.M. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett 580 22 (2006) 5177-5184
18. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., and Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80 2 (1995) 285-291
19. Gonzalez G.M., Perez B.R., Ding L., et al. Bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120 10 (1994) 3033-3042
20. Hu Y., Benedict M.A., Wu D., Inohara N., and Nunez C. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 95 8 (1998) 4386-4391
21. Chinnaiyan A.M., O'Rourke K., Lane B.R., and Dixit V.M. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275 5303 (1997) 1122-1126
22. Ishitsuka K., Hideshima T., Hamasaki M., et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and independent apoptosis. Blood 106 5 (2005) 1794-1800
23. Shigemura K., Arbiser J.L., Sun S.Y., et al. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109 7 (2007) 1279-1289
24. Li L., Han W.D., Gu Y., et al. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res 67 10 (2007) 4894-4903
25. Xu D., Lu Q.H., and Hu X. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243 2 (2006) 274-280
26. Chodorowska G., Chodorowski J., and Wysokinski A. Vascular endothelial growth factor (VEGF) in physiological and pathological conditions. Ann Univ Mariae Curie Sklodowska 59 3 (2004) 8-14
27. Ahn K.S., Setti G., Shishodia S., Sung B., Arbiser J.L., and Aggarwal B.B. Honokiol potentiates apoptosis, suppresses obsteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 4 9 (2006) 621-633
28. Zeng H., Dvorak H.F., and Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 276 29 (2001) 26969-26979
29. Soga N., Connolly J.O., Chellaiah M., Kawamura J., and Hruska K.A. Rac regulates vascular endothelial growth factor stimulated motility. Cell Commun Adhes 8 1 (2001) 1-13
30. Lee B.C., Doo H.K., Lee H.J., et al. The inhibitory effects of aqueous extract of Magnolia officinalis on human mesangial cell proliferation by regulation of platelet-derived growth factor-BB and transforming growth factor-beta 1 expression. J Pharmacol Sci 94 1 (2004) 81-85
31. Son H.J., Lee H.J., Yun Choi H.S., and Ryu J.H. Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. Planta Med 66 5 (2000) 469-471